|
Volumn 10, Issue 3, 1997, Pages 119-124
|
An economically rational method of managing early-stage endometriosis.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GONADORELIN;
HORMONE ANTAGONIST;
ARTICLE;
COST BENEFIT ANALYSIS;
DIFFERENTIAL DIAGNOSIS;
DRUG ANTAGONISM;
ECONOMICS;
ENDOMETRIOSIS;
FEMALE;
HEALTH CARE COST;
HUMAN;
LAPAROSCOPY;
PELVIS PAIN SYNDROME;
UNITED STATES;
COST-BENEFIT ANALYSIS;
DIAGNOSIS, DIFFERENTIAL;
ENDOMETRIOSIS;
FEMALE;
GONADOTROPIN-RELEASING HORMONE;
HEALTH CARE COSTS;
HORMONE ANTAGONISTS;
HUMANS;
LAPAROSCOPY;
PELVIC PAIN;
UNITED STATES;
|
EID: 0031088440
PISSN: 08964831
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (0)
|